BridgeBio Pharma, Inc.·4

Dec 12, 7:00 PM ET

STEPHENSON BRIAN C 4

4 · BridgeBio Pharma, Inc. · Filed Dec 12, 2024

Insider Transaction Report

Form 4
Period: 2024-12-10
STEPHENSON BRIAN C
Secretary, Treasurer & CFO
Transactions
  • Award

    Restricted Stock Units

    2024-12-10+42,68342,683 total
    Common Stock (42,683 underlying)
Footnotes (2)
  • [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F2]The RSUs vest with respect to 1/2 of the underlying shares on December 12, 2025. Thereafter, the remaining underlying shares shall vest on December 12, 2026, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4